OptimizeRx to Participate at Investor Conferences in September
September 09 2020 - 7:31AM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, providers and
patients, has been invited to participate in two investor
conferences being held in September.
Event: H.C. Wainwright’s 22nd Annual Global Investment
ConferenceDate: September 14-16, 2020Format: 1x1 meetings and live
company presentationWebcast date and time: September 16th at 1:00
p.m. EDTWebcast link: click herePlease contact your H.C. Wainwright
institutional sales representative for registration
information.
Event: Lake Street Capital Markets’ 4th Annual Best Ideas Growth
(BIG4) ConferenceDate: September 17, 2020Format: 1x1 meetingsPlease
contact your Lake Street institutional sales representative for
registration information.
OptimizeRx management is scheduled to participate in virtual
one-on-one meetings with institutional investors and analysts at
both conferences.
Management will discuss how OptimizeRx’s growing digital
point-of-care solutions have evolved into ‘must-haves’ for life
science companies looking to improve essential communications with
physicians and patients.
They will also discuss the company’s recent expansion of its
digital health platform from ambulatory and acute care to retail
pharmacy, which includes access to a new nationwide network of
10,000 FDA-cleared self-screening Smart Health Stations.
To schedule a virtual one-on-one meeting with OptimizeRx, you
may submit your request via the links provided upon your
registration for the conferences. For any questions about
OptimizeRx, please contact Ron Both of CMA at (949) 432-7557 or
submit your request here.
About H.C. WainwrightH.C. Wainwright is a
full‐service investment bank dedicated to providing corporate
finance, strategic advisory and related services to public and
private companies across multiple sectors and
regions. H.C. Wainwright & Co. also provides
research and sales and trading services to institutional
investors. According to Sagient Research Systems, H.C.
Wainwright’s team is ranked as the #1 Placement Agent in terms of
aggregate CMPO (confidentially marketed public offering), RD
(registered direct offering) and PIPE (private investment in public
equity) executed cumulatively since 1998. For more information
about H.C. Wainwright, visit www.hcwco.com.
About Lake Street Capital MarketsLake Street
Capital Markets is a research-powered investment bank focused on
select, high-growth companies and sectors of the economy. Their
research enables institutional investors to understand emerging
secular trends and identify innovative companies best positioned to
capitalize on them. Lake Street provides companies with access to
capital and helps build relationships to drive long-term growth. At
the core of everything it does is their commitment to providing
informed advice and exceptional service to its clients. For more
information about Lake Street, visit
www.lakestreetcapitalmarkets.com.
About OptimizeRxOptimizeRx Corporation (NASDAQ:
OPRX) is a digital health company that facilitates communication at
point-of-care among all stakeholders in healthcare. Primarily
focused on life science and payer clients, its suite of digital and
mobile SaaS-based solutions enables affordability, patient
adherence and care management. OptimizeRx’s network reaches more
than 60% of U.S. ambulatory providers, delivering therapeutic
support on specialty medications and patient financial assistance
directly within a provider’s workflow through leading electronic
health platforms. OptimizeRx’s fully integrated platform supports
the real-time exchange of information, improving provider knowledge
and patient engagement, and ultimately leading to healthier
outcomes.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material
risks.
OptimizeRx Contact Doug
Baker, CFOTel (248) 651-6568 (x807)dbaker@optimizerx.com
Media Relations Contact Maira Alejandra,
Media Relations ManagerTel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Apr 2023 to Apr 2024